BCL2 and acute lymphoblastic leukemia: Suppression of the STAT5 target genes PIM1 and BCL2 (PIM kinase inhibitor AZD1208 and BCL2 antagonist Sabutoclax) induced apoptosis in BCR–ABL+ ALL cells [164].